DI CARLO, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 3.911
EU - Europa 3.634
AS - Asia 1.996
SA - Sud America 11
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 9.563
Nazione #
US - Stati Uniti d'America 3.891
CN - Cina 811
UA - Ucraina 771
IE - Irlanda 629
TR - Turchia 554
GB - Regno Unito 484
SE - Svezia 448
SG - Singapore 444
IT - Italia 399
FR - Francia 358
DE - Germania 241
FI - Finlandia 147
IN - India 129
RU - Federazione Russa 116
VN - Vietnam 33
CA - Canada 13
BE - Belgio 12
IL - Israele 8
MX - Messico 7
AR - Argentina 5
CL - Cile 5
CZ - Repubblica Ceca 5
EG - Egitto 4
EU - Europa 4
RO - Romania 4
AT - Austria 3
ES - Italia 3
IR - Iran 3
KR - Corea 3
NL - Olanda 3
PK - Pakistan 3
AU - Australia 2
CH - Svizzera 2
GR - Grecia 2
JP - Giappone 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BY - Bielorussia 1
HU - Ungheria 1
LB - Libano 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 9.563
Città #
Jacksonville 841
Chandler 702
Dublin 626
Southend 387
Dearborn 382
Singapore 371
Princeton 310
Izmir 263
Nanjing 250
Wilmington 173
Cambridge 140
Beijing 138
Altamura 98
Nanchang 78
Ann Arbor 73
Boardman 69
New York 68
Santa Clara 68
Chieti 58
Woodbridge 54
Shenyang 47
Ashburn 40
Hebei 39
Romola 37
Kunming 36
Grevenbroich 34
Dong Ket 32
Jiaxing 30
Tianjin 26
Hangzhou 20
Hefei 20
Houston 20
Los Angeles 20
Jinan 19
Norwalk 18
Düsseldorf 17
Orange 16
Changsha 15
Guangzhou 14
Lanciano 12
Pescara 12
Brussels 11
Chennai 11
Falls Church 11
Helsinki 11
Auburn Hills 10
Augusta 9
Leawood 9
Washington 9
Changchun 8
Lanzhou 8
Ningbo 8
San Mateo 8
Toronto 7
Mexico City 6
Tappahannock 6
Munich 5
Porto San Giorgio 5
Tandil 5
Torino 5
Andover 4
Baotou 4
Brno 4
Milan 4
Moscow 4
Padova 4
Rome 4
Shanghai 4
Taizhou 4
Xian 4
Zhengzhou 4
Jülich 3
Layyah 3
Pune 3
Rouen 3
Seattle 3
Walnut 3
Amsterdam 2
Bangalore 2
Campobasso 2
Catanzaro 2
Cedar Knolls 2
Coimbatore 2
Collecorvino 2
Francavilla Al Mare 2
Frankfurt am Main 2
Fuzhou 2
Genoa 2
Gradara 2
Harbin 2
Irsina 2
Kocaeli 2
Lappeenranta 2
London 2
Mirandola 2
Montesilvano 2
Montesilvano Marina 2
Perugia 2
Redmond 2
San Giovanni Teatino 2
Totale 5.933
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 112
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 106
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 93
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 92
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 92
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 88
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 88
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 88
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 88
Targeting tumor-related immunosuppression for cancer immunotherapy. 86
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 86
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 85
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 84
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 83
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 83
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 83
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 83
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 83
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 82
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 82
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 82
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 82
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 81
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 81
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 80
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 80
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 80
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 79
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 78
The role of B lymphocytes and NK cells in cardiac allograft rejection. 78
Interleukin-30 Promotes Breast Cancer Growth and Progression 78
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 78
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 77
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 77
Neutrophils in anti-cancer immunological strategies: old players in new games 77
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 77
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 77
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 76
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 76
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 76
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 76
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 76
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 76
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 75
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 75
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 75
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 75
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 74
The Quilty Effect: an actor in search of a part 74
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 74
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 74
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 74
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 73
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 73
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 73
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 73
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 73
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 73
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 73
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 72
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 72
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 72
Immunological prevention of a multigene cancer syndrome. 71
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 71
Neutrophils in the antitumoral immune response 71
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 71
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 71
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 70
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 70
The antitumor potential of Interleukin-27 in prostate cancer 70
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 70
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 69
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 69
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 69
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 69
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 69
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. 68
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 68
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 67
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. 67
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 66
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma. 66
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 65
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 65
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 64
Mouse tumorigenesis models as an aid to understanding human cancer. 64
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 64
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 64
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 64
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice 63
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers 63
Gene trasfer of a secretable form of il-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response 62
The IL-12Rb2 gene protects from autoimmunity and functions as tumor suppressor in B cell malignancies. 62
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. 61
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. 61
Endogenous IL-12 triggers an antiangiogenic program in melanoma cells. 61
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 61
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 61
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 61
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy 60
Totale 7.470
Categoria #
all - tutte 36.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.364 0 0 0 92 148 256 308 219 44 93 178 26
2020/2021892 148 4 149 9 97 224 14 6 38 126 19 58
2021/2022585 29 9 8 91 52 16 11 52 40 25 71 181
2022/20232.099 175 212 114 254 222 442 114 142 290 51 54 29
2023/2024791 77 34 48 20 36 246 231 15 1 12 8 63
2024/2025850 157 318 316 59 0 0 0 0 0 0 0 0
Totale 10.075